Search filters

List of works by Michael Friedlander

2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer: Report From the Fourth Ovarian Cancer Consensus Conference ⬇️

scientific article published on May 1, 2011

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

A Specialist Breast Care Nurse Role for Women With Metastatic Breast Cancer: Enhancing Supportive Care ⬇️

scientific article published on 01 November 2011

A practical guide to understanding, using and including patient reported outcomes in clinical trials in ovarian cancer

scientific article published on 09 June 2018

Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort Consortium

scientific article published on 02 December 2019

Breast Cancer Chemoprevention: Use and Views of Australian Women and their Clinicians

scientific article published on 28 October 2020

Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial.

scientific article

Clinical Trials in Recurrent Ovarian Cancer ⬇️

scientific article published on May 1, 2011

Clinical Trials of Palliative Chemotherapy in Platinum-Resistant or -Refractory Ovarian Cancer: Time to Think Differently? ⬇️

scientific article published on May 13, 2013

Correction to: Survival from breast cancer in women with a BRCA2 mutation by treatment

scientific article published on 13 January 2023

Current academic clinical trials in ovarian cancer: Gynecologic Cancer Intergroup and US National Cancer Institute Clinical Trials Planning Meeting, May 2009

scientific article

Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional study

scientific article published on 06 August 2013

Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer

publication published on 23 June 2021

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.

scientific article

Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy.

scientific article published on 08 April 2016

Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial.

scientific article published on 08 September 2016

PARAGON (ANZGOG-0903): a phase 2 study of anastrozole in asymptomatic patients with estrogen and progesterone receptor-positive recurrent ovarian cancer and CA125 progression

scientific article published on 01 September 2019

Pre- and post-diagnosis diet quality and ovarian cancer survival

scientific article published on 03 November 2020

Primary Surgical Management With Tailored Adjuvant Radiation for Stage IB2 Cervical Cancer ⬇️

scientific article published on 01 April 2013

Recreational Physical Activity Is Associated with Reduced Breast Cancer Risk in Adult Women at High Risk for Breast Cancer: A Cohort Study of Women Selected for Familial and Genetic Risk

scientific article published on 02 October 2019

Survival Following Chemotherapy in Ovarian Clear Cell Carcinoma Is Not Associated with Pathological Misclassification of Tumor Histotype

scientific article published on 09 April 2019

Paulina is supported by:

About Paulina

Help